Dermata Historical Cash Flow
| DRMAW Stock | USD 0.03 0.00 0.000004% |
Analysis of Dermata Therapeutics cash flow over time is an excellent tool to project Dermata Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 1 M or Begin Period Cash Flow of 4.6 M as it is a great indicator of Dermata Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Dermata |
About Dermata Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Dermata balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Dermata's non-liquid assets can be easily converted into cash.
Dermata Therapeutics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Dermata Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Dermata Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dermata Therapeutics Warrant. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Dermata Stock please use our How to Invest in Dermata Therapeutics guide.At this time, Dermata Therapeutics' Stock Based Compensation is fairly stable compared to the past year. Change In Working Capital is likely to climb to about 1 M in 2025, whereas Free Cash Flow is likely to drop (6.1 M) in 2025.
Dermata Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Dermata Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dermata Therapeutics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (1.5M) | 10.3M | (4.6M) | 1.2M | 1.1M | 1.0M | |
| Stock Based Compensation | 0.0 | 1.9M | 930.3K | 522.1K | 600.4K | 738.9K | |
| Free Cash Flow | (4.0M) | (5.7M) | (8.8M) | (6.4M) | (5.8M) | (6.1M) | |
| Change In Working Capital | (755.8K) | 289.6K | (153.6K) | 863.7K | 993.2K | 1.0M | |
| Begin Period Cash Flow | 2.0M | 530.4K | 10.8M | 6.2M | 7.2M | 4.6M | |
| Other Cashflows From Financing Activities | 3.2M | (430K) | 287.0 | 187.0 | 168.3 | 159.89 | |
| Other Non Cash Items | (36.5K) | 14.1K | 930.3K | 522.1K | 600.4K | 506.6K | |
| Total Cash From Operating Activities | (4.0M) | (5.7M) | (8.8M) | (6.4M) | (5.8M) | (6.1M) | |
| Issuance Of Capital Stock | 268.8K | 16.0M | 4.3M | 5.7M | 6.5M | 6.9M | |
| Net Income | (3.2M) | (7.9M) | (9.6M) | (7.8M) | (7.0M) | (7.4M) | |
| Total Cash From Financing Activities | 2.6M | 16.0M | 4.3M | 7.6M | 8.7M | 7.7M | |
| End Period Cash Flow | 530.4K | 10.8M | 6.2M | 7.4M | 8.6M | 5.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Dermata Stock Analysis
When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.